Global Brachytherapy Market – Industry Analysis and Forecast (2019-2027) – By Technique, Product, Application, End User, and Region.

Global Brachytherapy market size was US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a CAGR of 4.7% during the forecast period. Global Brachytherapy Market To know about the Research Methodology :- Request Free Sample Report The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Global Brachytherapy market Definition

Brachytherapy is the type of radiotherapy that is widely used to treat cancers such as prostate, breast, skin, and others. In Brachytherapy radioactive material called source is placed inside the body of cancer patients in order to kill cancer cells and to shrink tumours.

Global Brachytherapy market Dynamics

The g4rowing use of Brachytherapy by doctors to treat various cancers such as prostate, skin, breast, stomach, cervix, brain, neck, lung, and many others is a major driving factor behind the growth of the market. Growing technological advancements in Brachytherapy, increasing investment by market players for research and development activities in this field, growing adoption of negligible invasive surgeries, rising number of cancer patients across the globe, and surging demand to treat cancer at the first stage are expected to improve the growth of the market during the forecast period. Brachytherapy provides some major benefits such as effective treatment of cancer, high level of accuracy, and high possibility of permanently curing cancer, which ultimately propels the market growth. However, the possibility of side effects to the area being treated and the availability of alternative cancer treatment methods are major restraining factors that could hamper the growth of the market.

Global Brachytherapy Market: Segmentation Analysis

By technique, a high dose rate (HDR) Brachytherapy segment dominated the market in 2019 and is expected to maintain its dominance at CAGR of XX% during the forecast period. HDR Brachytherapy is the type of internal radiotherapy. It is a dominant treatment method of internally delivered radiation therapy that kills various kinds of cancer cells such as prostate, skin, breast, and cervical. HDR Brachytherapy provides some benefits such as highly accurate internally delivered radiation therapy, convenient treatment, generally pain-free treatment, and reduced risk of common long- and short- term side effects, which makes them the most used treatment method for cancer. By application, the prostate cancer segment dominated the market in 2019 and is projected to witness fast growth at CAGR of XX% during the forecast period. Prostate cancer is that kind of cancer which develops in the prostate gland and one of the most common types of cancer that occurs in the men worldwide. According to research, it is found that, in 2018, 1.3 million new cases of prostate cancer are registered globally and most importantly 6 out of 10 men have a risk of getting diagnosed with prostate cancer in their lifetime. The incidence rate of prostate cancers is highest in North America, and Australia/New Zealand. Age-standardized incidence rates of prostate cancer have increased noticeably. The increasing age-adjusted incidence rate of prostate cancer worldwide is expected to improve the growth of the market during the forecast period. Alternatively, the breast cancer segment is projected to witness fast growth at CAGR of XX% during the forecast period. Increasing incidence of breast cancer among women across the world is impelling the growth of the market.

Global Brachytherapy Market: Regional Analysis

Region-wise, North America dominated the market in 2019 and is expected to maintain its dominance at a CAGR of XX% during the forecast period. The US and Canada are the major contributors behind the growth of the market in the region. The growth is attributed to the increasing use of the Brachytherapy treatment method to cure cancer patients across the region. An increasing number of prostates, lung, breast, bronchus, and colorectal cancer patients across the US is driving the growth of the market across the region. These types of cancer are accounted for nearly 50% of all cancer cases in the United States. It is estimated that by the end of 2020, there will be approximately 1.8 Mn people will be diagnosed with cancer in the United States. Breast cancer and prostate cancer are the most common cancer types that are occurred in men and women of the US. As per MMR study, approximately 276,480 women and 2,620 men will be diagnosed with breast cancer and 191,930 men will be diagnosed with prostate cancer by 2020. Estimated Number of Cancer Patients and Deaths in the US by the End of 2020- The objective of the report is to present a comprehensive analysis of the Global Brachytherapy Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Brachytherapy Market dynamics, structure by analyzing the market segments and projects the Global Brachytherapy Market. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Brachytherapy Market make the report investor’s guide.

The Scope of Global Brachytherapy Market: Inquire before buying

Global Brachytherapy Market, By Technique

• High Dose Rate (HDR) Brachytherapy • Low Dose Rate (LDR) Brachytherapy • Pulse Dose Rate (PDR) Brachytherapy • Image Guided Brachytherapy (IGBT)

Global Brachytherapy Market, By Product

• Brachytherapy After Loader • Brachytherapy Applicators o Intracavitary Applicators o Intraluminal Applicators o Interstitial Applicators o Intraoperative and Surface Applicators • Brachytherapy Software

Global Brachytherapy Market, By Application

• Prostate Cancer • Breast Cancer • Gynecological Cancer • Cervical Cancer • Skin Cancer • Others (Lung, Head, Neck)

Global Brachytherapy Market, By End User

• Hospitals • Specialty Clinics • Others

Global Brachytherapy Market, By Region

• North America • Europe • Asia Pacific • South America • Middle East and Africa

Global Brachytherapy Market, Key Players

Global Players • Boston Scientific • C4 Imaging • CIVCO Radiotherapy • Concure Oncology’s • Elekta AB • Varian Medical Systems • Theragenics Corporation • iCAD Inc • IsoAid • C. R. Bard, Inc • Sun Nuclear Corporation • Mevion Medical Systems, Inc • XX • XX North America • IsoRay Medical, Inc • Argon Medical Devices, Inc • Cianna Medical • XX • XX Europe • Eckert & Ziegler • XX • XX Asia Pacific • Hitachi, Ltd • Panacea Medical Technologies Pvt. Ltd • XX • XX South America • Elketa Mexico • XX • XX MEA • XX • XX
Global Brachytherapy Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Brachytherapy Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Brachytherapy Market Analysis and Forecast 6.1. Brachytherapy Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Brachytherapy Market Analysis and Forecast, By Technique 7.1. Introduction and Definition 7.2. Key Findings 7.3. Brachytherapy Market Value Share Analysis, By Technique 7.4. Brachytherapy Market Size (US$ Bn) Forecast, By Technique 7.5. Brachytherapy Market Analysis, By Technique 7.6. Brachytherapy Market Attractiveness Analysis, By Technique 8. Global Brachytherapy Market Analysis and Forecast, By Product 8.1. Introduction and Definition 8.2. Key Findings 8.3. Brachytherapy Market Value Share Analysis, By Product 8.4. Brachytherapy Market Size (US$ Bn) Forecast, By Product 8.5. Brachytherapy Market Analysis, By Product 8.6. Brachytherapy Market Attractiveness Analysis, By Product 9. Global Brachytherapy Market Analysis and Forecast, By Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Brachytherapy Market Value Share Analysis, By Application 9.4. Brachytherapy Market Size (US$ Bn) Forecast, By Application 9.5. Brachytherapy Market Analysis, By Application 9.6. Brachytherapy Market Attractiveness Analysis, By Application 10. Global Brachytherapy Market Analysis and Forecast, By End User 10.1. Introduction and Definition 10.2. Key Findings 10.3. Brachytherapy Market Value Share Analysis, By End User 10.4. Brachytherapy Market Size (US$ Bn) Forecast, By End User 10.5. Brachytherapy Market Analysis, By End User 10.6. Brachytherapy Market Attractiveness Analysis, By End User 11. Global Brachytherapy Market Analysis, by Region 11.1. Brachytherapy Market Value Share Analysis, by Region 11.2. Brachytherapy Market Size (US$ Bn) Forecast, by Region 11.3. Brachytherapy Market Attractiveness Analysis, by Region 12. North America Brachytherapy Market Analysis 12.1. Key Findings 12.2. North America Brachytherapy Market Overview 12.3. North America Brachytherapy Market Value Share Analysis, By Technique 12.4. North America Brachytherapy Market Forecast, By Technique 12.4.1. High Dose Rate (HDR) Brachytherapy 12.4.2. Low Dose Rate (LDR) Brachytherapy 12.4.3. Pulse Dose Rate (PDR) Brachytherapy 12.4.4. Image Guided Brachytherapy (IGBT) 12.5. North America Brachytherapy Market Value Share Analysis, By Product 12.6. North America Brachytherapy Market Forecast, By Product 12.6.1. Brachytherapy After Loader 12.6.2. Brachytherapy Applicators 12.6.2.1. Intracavitary Applicators 12.6.2.2. Intraluminal Applicators 12.6.2.3. Interstitial Applicators 12.6.2.4. Intraoperative and Surface Applicators 12.6.3. Brachytherapy Software 12.7. North America Brachytherapy Market Value Share Analysis, By Application 12.8. North America Brachytherapy Market Forecast, By Application 12.8.1. Prostate Cancer 12.8.2. Breast Cancer 12.8.3. Gynecological Cancer 12.8.4. Cervical Cancer 12.8.5. Skin Cancer 12.8.6. Others (Lung, Head, Neck) 12.9. North America Brachytherapy Market Value Share Analysis, By End User 12.10. North America Brachytherapy Market Forecast, By End User 12.10.1. Hospitals 12.10.2. Specialty Clinics 12.10.3. Others 12.11. North America Brachytherapy Market Value Share Analysis, by Country 12.12. North America Brachytherapy Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Brachytherapy Market Analysis, by Country 12.14. U.S. Brachytherapy Market Forecast, By Technique 12.14.1. High Dose Rate (HDR) Brachytherapy 12.14.2. Low Dose Rate (LDR) Brachytherapy 12.14.3. Pulse Dose Rate (PDR) Brachytherapy 12.14.4. Image Guided Brachytherapy (IGBT) 12.15. U.S. Brachytherapy Market Forecast, By Product 12.15.1. Brachytherapy After Loader 12.15.2. Brachytherapy Applicators 12.15.2.1. Intracavitary Applicators 12.15.2.2. Intraluminal Applicators 12.15.2.3. Interstitial Applicators 12.15.2.4. Intraoperative and Surface Applicators 12.15.3. Brachytherapy Software 12.16. U.S. Brachytherapy Market Forecast, By Application 12.16.1. Prostate Cancer 12.16.2. Breast Cancer 12.16.3. Gynecological Cancer 12.16.4. Cervical Cancer 12.16.5. Skin Cancer 12.16.6. Others (Lung, Head, Neck) 12.17. U.S. Brachytherapy Market Forecast, By End User 12.17.1. Hospitals 12.17.2. Specialty Clinics 12.17.3. Others 12.18. Canada Brachytherapy Market Forecast, By Technique 12.18.1. High Dose Rate (HDR) Brachytherapy 12.18.2. Low Dose Rate (LDR) Brachytherapy 12.18.3. Pulse Dose Rate (PDR) Brachytherapy 12.18.4. Image Guided Brachytherapy (IGBT) 12.19. Canada Brachytherapy Market Forecast, By Product 12.19.1. Brachytherapy After Loader 12.19.2. Brachytherapy Applicators 12.19.2.1. Intracavitary Applicators 12.19.2.2. Intraluminal Applicators 12.19.2.3. Interstitial Applicators 12.19.2.4. Intraoperative and Surface Applicators 12.19.3. Brachytherapy Software 12.20. Canada Brachytherapy Market Forecast, By Application 12.20.1. Prostate Cancer 12.20.2. Breast Cancer 12.20.3. Gynecological Cancer 12.20.4. Cervical Cancer 12.20.5. Skin Cancer 12.20.6. Others (Lung, Head, Neck) 12.21. Canada Brachytherapy Market Forecast, By End User 12.21.1. Hospitals 12.21.2. Specialty Clinics 12.21.3. Others 12.22. North America Brachytherapy Market Attractiveness Analysis 12.22.1. By Technique 12.22.2. By Product 12.22.3. By Application 12.22.4. By End User 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Brachytherapy Market Analysis 13.1. Key Findings 13.2. Europe Brachytherapy Market Overview 13.3. Europe Brachytherapy Market Value Share Analysis, By Technique 13.4. Europe Brachytherapy Market Forecast, By Technique 13.4.1. High Dose Rate (HDR) Brachytherapy 13.4.2. Low Dose Rate (LDR) Brachytherapy 13.4.3. Pulse Dose Rate (PDR) Brachytherapy 13.4.4. Image Guided Brachytherapy (IGBT) 13.5. Europe Brachytherapy Market Value Share Analysis, By Product 13.6. Europe Brachytherapy Market Forecast, By Product 13.6.1. Brachytherapy After Loader 13.6.2. Brachytherapy Applicators 13.6.2.1. Intracavitary Applicators 13.6.2.2. Intraluminal Applicators 13.6.2.3. Interstitial Applicators 13.6.2.4. Intraoperative and Surface Applicators 13.6.3. Brachytherapy Software 13.7. Europe Brachytherapy Market Value Share Analysis, By Application 13.8. Europe Brachytherapy Market Forecast, By Application 13.8.1. Prostate Cancer 13.8.2. Breast Cancer 13.8.3. Gynecological Cancer 13.8.4. Cervical Cancer 13.8.5. Skin Cancer 13.8.6. Others (Lung, Head, Neck) 13.9. Europe Brachytherapy Market Value Share Analysis, By End User 13.10. Europe Brachytherapy Market Forecast, By End User 13.10.1. Hospitals 13.10.2. Specialty Clinics 13.10.3. Others 13.11. Europe Brachytherapy Market Value Share Analysis, by Country 13.12. Europe Brachytherapy Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Brachytherapy Market Analysis, by Country 13.14. Germany Brachytherapy Market Forecast, By Technique 13.14.1. High Dose Rate (HDR) Brachytherapy 13.14.2. Low Dose Rate (LDR) Brachytherapy 13.14.3. Pulse Dose Rate (PDR) Brachytherapy 13.14.4. Image Guided Brachytherapy (IGBT) 13.15. Germany Brachytherapy Market Forecast, By Product 13.15.1. Brachytherapy After Loader 13.15.2. Brachytherapy Applicators 13.15.2.1. Intracavitary Applicators 13.15.2.2. Intraluminal Applicators 13.15.2.3. Interstitial Applicators 13.15.2.4. Intraoperative and Surface Applicators 13.15.3. Brachytherapy Software 13.16. Germany Brachytherapy Market Forecast, By Application 13.16.1. Prostate Cancer 13.16.2. Breast Cancer 13.16.3. Gynecological Cancer 13.16.4. Cervical Cancer 13.16.5. Skin Cancer 13.16.6. Others (Lung, Head, Neck) 13.17. Germany Brachytherapy Market Forecast, By End User 13.17.1. Hospitals 13.17.2. Specialty Clinics 13.17.3. Others 13.18. U.K. Brachytherapy Market Forecast, By Technique 13.18.1. High Dose Rate (HDR) Brachytherapy 13.18.2. Low Dose Rate (LDR) Brachytherapy 13.18.3. Pulse Dose Rate (PDR) Brachytherapy 13.18.4. Image Guided Brachytherapy (IGBT) 13.19. U.K. Brachytherapy Market Forecast, By Product 13.19.1. Brachytherapy After Loader 13.19.2. Brachytherapy Applicators 13.19.2.1. Intracavitary Applicators 13.19.2.2. Intraluminal Applicators 13.19.2.3. Interstitial Applicators 13.19.2.4. Intraoperative and Surface Applicators 13.19.3. Brachytherapy Software 13.20. U.K. Brachytherapy Market Forecast, By Application 13.20.1. Prostate Cancer 13.20.2. Breast Cancer 13.20.3. Gynecological Cancer 13.20.4. Cervical Cancer 13.20.5. Skin Cancer 13.20.6. Others (Lung, Head, Neck) 13.21. U.K. Brachytherapy Market Forecast, By End User 13.21.1. Hospitals 13.21.2. Specialty Clinics 13.21.3. Others 13.22. France Brachytherapy Market Forecast, By Technique 13.22.1. High Dose Rate (HDR) Brachytherapy 13.22.2. Low Dose Rate (LDR) Brachytherapy 13.22.3. Pulse Dose Rate (PDR) Brachytherapy 13.22.4. Image Guided Brachytherapy (IGBT) 13.23. France Brachytherapy Market Forecast, By Product 13.23.1. Brachytherapy After Loader 13.23.2. Brachytherapy Applicators 13.23.2.1. Intracavitary Applicators 13.23.2.2. Intraluminal Applicators 13.23.2.3. Interstitial Applicators 13.23.2.4. Intraoperative and Surface Applicators 13.23.3. Brachytherapy Software 13.24. France Brachytherapy Market Forecast, By Application 13.24.1. Prostate Cancer 13.24.2. Breast Cancer 13.24.3. Gynecological Cancer 13.24.4. Cervical Cancer 13.24.5. Skin Cancer 13.24.6. Others (Lung, Head, Neck) 13.25. France Brachytherapy Market Forecast, By End User 13.25.1. Hospitals 13.25.2. Specialty Clinics 13.25.3. Others 13.26. Italy Brachytherapy Market Forecast, By Technique 13.26.1. High Dose Rate (HDR) Brachytherapy 13.26.2. Low Dose Rate (LDR) Brachytherapy 13.26.3. Pulse Dose Rate (PDR) Brachytherapy 13.26.4. Image Guided Brachytherapy (IGBT) 13.27. Italy Brachytherapy Market Forecast, By Product 13.27.1. Brachytherapy After Loader 13.27.2. Brachytherapy Applicators 13.27.2.1. Intracavitary Applicators 13.27.2.2. Intraluminal Applicators 13.27.2.3. Interstitial Applicators 13.27.2.4. Intraoperative and Surface Applicators 13.27.3. Brachytherapy Software 13.28. Italy Brachytherapy Market Forecast, By Application 13.28.1. Prostate Cancer 13.28.2. Breast Cancer 13.28.3. Gynecological Cancer 13.28.4. Cervical Cancer 13.28.5. Skin Cancer 13.28.6. Others (Lung, Head, Neck) 13.29. Italy Brachytherapy Market Forecast, By End User 13.29.1. Hospitals 13.29.2. Specialty Clinics 13.29.3. Others 13.30. Spain Brachytherapy Market Forecast, By Technique 13.30.1. High Dose Rate (HDR) Brachytherapy 13.30.2. Low Dose Rate (LDR) Brachytherapy 13.30.3. Pulse Dose Rate (PDR) Brachytherapy 13.30.4. Image Guided Brachytherapy (IGBT) 13.31. Spain Brachytherapy Market Forecast, By Product 13.31.1. Brachytherapy After Loader 13.31.2. Brachytherapy Applicators 13.31.2.1. Intracavitary Applicators 13.31.2.2. Intraluminal Applicators 13.31.2.3. Interstitial Applicators 13.31.2.4. Intraoperative and Surface Applicators 13.31.3. Brachytherapy Software 13.32. Spain Brachytherapy Market Forecast, By Application 13.32.1. Prostate Cancer 13.32.2. Breast Cancer 13.32.3. Gynecological Cancer 13.32.4. Cervical Cancer 13.32.5. Skin Cancer 13.32.6. Others (Lung, Head, Neck) 13.33. Spain Brachytherapy Market Forecast, By End User 13.33.1. Hospitals 13.33.2. Specialty Clinics 13.33.3. Others 13.34. Rest of Europe Brachytherapy Market Forecast, By Technique 13.34.1. High Dose Rate (HDR) Brachytherapy 13.34.2. Low Dose Rate (LDR) Brachytherapy 13.34.3. Pulse Dose Rate (PDR) Brachytherapy 13.34.4. Image Guided Brachytherapy (IGBT) 13.35. Rest of Europe Brachytherapy Market Forecast, By Product 13.35.1. Brachytherapy After Loader 13.35.2. Brachytherapy Applicators 13.35.2.1. Intracavitary Applicators 13.35.2.2. Intraluminal Applicators 13.35.2.3. Interstitial Applicators 13.35.2.4. Intraoperative and Surface Applicators 13.35.3. Brachytherapy Software 13.36. Rest of Europe Brachytherapy Market Forecast, By Application 13.36.1. Prostate Cancer 13.36.2. Breast Cancer 13.36.3. Gynecological Cancer 13.36.4. Cervical Cancer 13.36.5. Skin Cancer 13.36.6. Others (Lung, Head, Neck) 13.37. Rest Of Europe Brachytherapy Market Forecast, By End User 13.37.1. Hospitals 13.37.2. Specialty Clinics 13.37.3. Others 13.38. Europe Brachytherapy Market Attractiveness Analysis 13.38.1. By Technique 13.38.2. By Product 13.38.3. By Application 13.38.4. By End User 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Brachytherapy Market Analysis 14.1. Key Findings 14.2. Asia Pacific Brachytherapy Market Overview 14.3. Asia Pacific Brachytherapy Market Value Share Analysis, By Technique 14.4. Asia Pacific Brachytherapy Market Forecast, By Technique 14.4.1. High Dose Rate (HDR) Brachytherapy 14.4.2. Low Dose Rate (LDR) Brachytherapy 14.4.3. Pulse Dose Rate (PDR) Brachytherapy 14.4.4. Image Guided Brachytherapy (IGBT) 14.5. Asia Pacific Brachytherapy Market Value Share Analysis, By Product 14.6. Asia Pacific Brachytherapy Market Forecast, By Product 14.6.1. Brachytherapy After Loader 14.6.2. Brachytherapy Applicators 14.6.2.1. Intracavitary Applicators 14.6.2.2. Intraluminal Applicators 14.6.2.3. Interstitial Applicators 14.6.2.4. Intraoperative and Surface Applicators 14.6.3. Brachytherapy Software 14.7. Asia Pacific Brachytherapy Market Value Share Analysis, By Application 14.8. Asia Pacific Brachytherapy Market Forecast, By Application 14.8.1. Prostate Cancer 14.8.2. Breast Cancer 14.8.3. Gynecological Cancer 14.8.4. Cervical Cancer 14.8.5. Skin Cancer 14.8.6. Others (Lung, Head, Neck) 14.9. Asia Pacific Brachytherapy Market Value Share Analysis, By End User 14.10. Asia Pacific Brachytherapy Market Forecast, By End User 14.10.1. Hospitals 14.10.2. Specialty Clinics 14.10.3. Others 14.11. Asia Pacific Brachytherapy Market Value Share Analysis, by Country 14.12. Asia Pacific Brachytherapy Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Brachytherapy Market Analysis, by Country 14.14. China Brachytherapy Market Forecast, By Technique 14.14.1. High Dose Rate (HDR) Brachytherapy 14.14.2. Low Dose Rate (LDR) Brachytherapy 14.14.3. Pulse Dose Rate (PDR) Brachytherapy 14.14.4. Image Guided Brachytherapy (IGBT) 14.15. China Brachytherapy Market Forecast, By Product 14.15.1. Brachytherapy After Loader 14.15.2. Brachytherapy Applicators 14.15.2.1. Intracavitary Applicators 14.15.2.2. Intraluminal Applicators 14.15.2.3. Interstitial Applicators 14.15.2.4. Intraoperative and Surface Applicators 14.15.3. Brachytherapy Software 14.16. China Brachytherapy Market Forecast, By Application 14.16.1. Prostate Cancer 14.16.2. Breast Cancer 14.16.3. Gynecological Cancer 14.16.4. Cervical Cancer 14.16.5. Skin Cancer 14.16.6. Others (Lung, Head, Neck) 14.17. China Brachytherapy Market Forecast, By End User 14.17.1. Hospitals 14.17.2. Specialty Clinics 14.17.3. Others 14.18. India Brachytherapy Market Forecast, By Technique 14.18.1. High Dose Rate (HDR) Brachytherapy 14.18.2. Low Dose Rate (LDR) Brachytherapy 14.18.3. Pulse Dose Rate (PDR) Brachytherapy 14.18.4. Image Guided Brachytherapy (IGBT) 14.19. India Brachytherapy Market Forecast, By Product 14.19.1. Brachytherapy After Loader 14.19.2. Brachytherapy Applicators 14.19.2.1. Intracavitary Applicators 14.19.2.2. Intraluminal Applicators 14.19.2.3. Interstitial Applicators 14.19.2.4. Intraoperative and Surface Applicators 14.19.3. Brachytherapy Software 14.20. India Brachytherapy Market Forecast, By Application 14.20.1. Prostate Cancer 14.20.2. Breast Cancer 14.20.3. Gynecological Cancer 14.20.4. Cervical Cancer 14.20.5. Skin Cancer 14.20.6. Others (Lung, Head, Neck) 14.21. India Brachytherapy Market Forecast, By End User 14.21.1. Hospitals 14.21.2. Specialty Clinics 14.21.3. Others 14.22. Japan Brachytherapy Market Forecast, By Technique 14.22.1. High Dose Rate (HDR) Brachytherapy 14.22.2. Low Dose Rate (LDR) Brachytherapy 14.22.3. Pulse Dose Rate (PDR) Brachytherapy 14.22.4. Image Guided Brachytherapy (IGBT) 14.23. Japan Brachytherapy Market Forecast, By Product 14.23.1. Brachytherapy After Loader 14.23.2. Brachytherapy Applicators 14.23.2.1. Intracavitary Applicators 14.23.2.2. Intraluminal Applicators 14.23.2.3. Interstitial Applicators 14.23.2.4. Intraoperative and Surface Applicators 14.23.3. Brachytherapy Software 14.24. Japan Brachytherapy Market Forecast, By Application 14.24.1. Prostate Cancer 14.24.2. Breast Cancer 14.24.3. Gynecological Cancer 14.24.4. Cervical Cancer 14.24.5. Skin Cancer 14.24.6. Others (Lung, Head, Neck) 14.25. Japan Brachytherapy Market Forecast, By End User 14.25.1. Hospitals 14.25.2. Specialty Clinics 14.25.3. Others 14.26. ASEAN Brachytherapy Market Forecast, By Technique 14.26.1. High Dose Rate (HDR) Brachytherapy 14.26.2. Low Dose Rate (LDR) Brachytherapy 14.26.3. Pulse Dose Rate (PDR) Brachytherapy 14.26.4. Image Guided Brachytherapy (IGBT) 14.27. ASEAN Brachytherapy Market Forecast, By Product 14.27.1. Brachytherapy After Loader 14.27.2. Brachytherapy Applicators 14.27.2.1. Intracavitary Applicators 14.27.2.2. Intraluminal Applicators 14.27.2.3. Interstitial Applicators 14.27.2.4. Intraoperative and Surface Applicators 14.27.3. Brachytherapy Software 14.28. ASEAN Brachytherapy Market Forecast, By Application 14.28.1. Prostate Cancer 14.28.2. Breast Cancer 14.28.3. Gynecological Cancer 14.28.4. Cervical Cancer 14.28.5. Skin Cancer 14.28.6. Others (Lung, Head, Neck) 14.29. ASEAN Brachytherapy Market Forecast, By End User 14.29.1. Hospitals 14.29.2. Specialty Clinics 14.29.3. Others 14.30. Rest of Asia Pacific Brachytherapy Market Forecast, By Technique 14.30.1. High Dose Rate (HDR) Brachytherapy 14.30.2. Low Dose Rate (LDR) Brachytherapy 14.30.3. Pulse Dose Rate (PDR) Brachytherapy 14.30.4. Image Guided Brachytherapy (IGBT) 14.31. Rest of Asia Pacific Brachytherapy Market Forecast, By Product 14.31.1. Brachytherapy After Loader 14.31.2. Brachytherapy Applicators 14.31.2.1. Intracavitary Applicators 14.31.2.2. Intraluminal Applicators 14.31.2.3. Interstitial Applicators 14.31.2.4. Intraoperative and Surface Applicators 14.31.3. Brachytherapy Software 14.32. Rest of Asia Pacific Brachytherapy Market Forecast, By Application 14.32.1. Prostate Cancer 14.32.2. Breast Cancer 14.32.3. Gynecological Cancer 14.32.4. Cervical Cancer 14.32.5. Skin Cancer 14.32.6. Others (Lung, Head, Neck) 14.33. Rest of Asia Pacific Brachytherapy Market Forecast, By End User 14.33.1. Hospitals 14.33.2. Specialty Clinics 14.33.3. Others 14.34. Asia Pacific Brachytherapy Market Attractiveness Analysis 14.34.1. By Technique 14.34.2. By Product 14.34.3. By Application 14.34.4. By End User 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Brachytherapy Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Brachytherapy Market Overview 15.3. Middle East & Africa Brachytherapy Market Value Share Analysis, By Technique 15.4. Middle East & Africa Brachytherapy Market Forecast, By Technique 15.4.1. High Dose Rate (HDR) Brachytherapy 15.4.2. Low Dose Rate (LDR) Brachytherapy 15.4.3. Pulse Dose Rate (PDR) Brachytherapy 15.4.4. Image Guided Brachytherapy (IGBT) 15.5. Middle East & Africa Brachytherapy Market Value Share Analysis, By Product 15.6. Middle East & Africa Brachytherapy Market Forecast, By Product 15.6.1. Brachytherapy After Loader 15.6.2. Brachytherapy Applicators 15.6.2.1. Intracavitary Applicators 15.6.2.2. Intraluminal Applicators 15.6.2.3. Interstitial Applicators 15.6.2.4. Intraoperative and Surface Applicators 15.6.3. Brachytherapy Software 15.7. Middle East & Africa Brachytherapy Market Value Share Analysis, By Application 15.8. Middle East & Africa Brachytherapy Market Forecast, By Application 15.8.1. Prostate Cancer 15.8.2. Breast Cancer 15.8.3. Gynecological Cancer 15.8.4. Cervical Cancer 15.8.5. Skin Cancer 15.8.6. Others (Lung, Head, Neck) 15.9. Middle East & Africa Brachytherapy Market Value Share Analysis, By End User 15.10. Middle East & Africa Brachytherapy Market Forecast, By End User 15.10.1. Hospitals 15.10.2. Specialty Clinics 15.10.3. Others 15.11. Middle East & Africa Brachytherapy Market Value Share Analysis, by Country 15.12. Middle East & Africa Brachytherapy Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Brachytherapy Market Analysis, by Country 15.14. GCC Brachytherapy Market Forecast, By Technique 15.14.1. High Dose Rate (HDR) Brachytherapy 15.14.2. Low Dose Rate (LDR) Brachytherapy 15.14.3. Pulse Dose Rate (PDR) Brachytherapy 15.14.4. Image Guided Brachytherapy (IGBT) 15.15. GCC Brachytherapy Market Forecast, By Product 15.15.1. Brachytherapy After Loader 15.15.2. Brachytherapy Applicators 15.15.2.1. Intracavitary Applicators 15.15.2.2. Intraluminal Applicators 15.15.2.3. Interstitial Applicators 15.15.2.4. Intraoperative and Surface Applicators 15.15.3. Brachytherapy Software 15.16. GCC Brachytherapy Market Forecast, By Application 15.16.1. Prostate Cancer 15.16.2. Breast Cancer 15.16.3. Gynecological Cancer 15.16.4. Cervical Cancer 15.16.5. Skin Cancer 15.16.6. Others (Lung, Head, Neck) 15.17. GCC Brachytherapy Market Forecast, By End User 15.17.1. Hospitals 15.17.2. Specialty Clinics 15.17.3. Others 15.18. South Africa Brachytherapy Market Forecast, By Technique 15.18.1. High Dose Rate (HDR) Brachytherapy 15.18.2. Low Dose Rate (LDR) Brachytherapy 15.18.3. Pulse Dose Rate (PDR) Brachytherapy 15.18.4. Image Guided Brachytherapy (IGBT) 15.19. South Africa Brachytherapy Market Forecast, By Product 15.19.1. Brachytherapy After Loader 15.19.2. Brachytherapy Applicators 15.19.2.1. Intracavitary Applicators 15.19.2.2. Intraluminal Applicators 15.19.2.3. Interstitial Applicators 15.19.2.4. Intraoperative and Surface Applicators 15.19.3. Brachytherapy Software 15.20. South Africa Brachytherapy Market Forecast, By Application 15.20.1. Prostate Cancer 15.20.2. Breast Cancer 15.20.3. Gynecological Cancer 15.20.4. Cervical Cancer 15.20.5. Skin Cancer 15.20.6. Others (Lung, Head, Neck) 15.21. South Africa Brachytherapy Market Forecast, By End User 15.21.1. Hospitals 15.21.2. Specialty Clinics 15.21.3. Others 15.22. Rest of Middle East & Africa Brachytherapy Market Forecast, By Technique 15.22.1. High Dose Rate (HDR) Brachytherapy 15.22.2. Low Dose Rate (LDR) Brachytherapy 15.22.3. Pulse Dose Rate (PDR) Brachytherapy 15.22.4. Image Guided Brachytherapy (IGBT) 15.23. Rest of Middle East & Africa Brachytherapy Market Forecast, By Product 15.23.1. Brachytherapy After Loader 15.23.2. Brachytherapy Applicators 15.23.2.1. Intracavitary Applicators 15.23.2.2. Intraluminal Applicators 15.23.2.3. Interstitial Applicators 15.23.2.4. Intraoperative and Surface Applicators 15.23.3. Brachytherapy Software 15.24. Rest of Middle East & Africa Brachytherapy Market Forecast, By Application 15.24.1. Prostate Cancer 15.24.2. Breast Cancer 15.24.3. Gynecological Cancer 15.24.4. Cervical Cancer 15.24.5. Skin Cancer 15.24.6. Others (Lung, Head, Neck) 15.25. Rest of Middle East & Africa Brachytherapy Market Forecast, By End User 15.25.1. Hospitals 15.25.2. Specialty Clinics 15.25.3. Others 15.26. Middle East & Africa Brachytherapy Market Attractiveness Analysis 15.26.1. By Technique 15.26.2. By Product 15.26.3. By Application 15.26.4. By End User 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Brachytherapy Market Analysis 16.1. Key Findings 16.2. South America Brachytherapy Market Overview 16.3. South America Brachytherapy Market Value Share Analysis, By Technique 16.4. South America Brachytherapy Market Forecast, By Technique 16.4.1. High Dose Rate (HDR) Brachytherapy 16.4.2. Low Dose Rate (LDR) Brachytherapy 16.4.3. Pulse Dose Rate (PDR) Brachytherapy 16.4.4. Image Guided Brachytherapy (IGBT) 16.5. South America Brachytherapy Market Value Share Analysis, By Product 16.6. South America Brachytherapy Market Forecast, By Product 16.6.1. Brachytherapy After Loader 16.6.2. Brachytherapy Applicators 16.6.2.1. Intracavitary Applicators 16.6.2.2. Intraluminal Applicators 16.6.2.3. Interstitial Applicators 16.6.2.4. Intraoperative and Surface Applicators 16.6.3. Brachytherapy Software 16.7. South America Brachytherapy Market Value Share Analysis, By Application 16.8. South America Brachytherapy Market Forecast, By Application 16.8.1. Prostate Cancer 16.8.2. Breast Cancer 16.8.3. Gynecological Cancer 16.8.4. Cervical Cancer 16.8.5. Skin Cancer 16.8.6. Others (Lung, Head, Neck) 16.9. South America Brachytherapy Market Value Share Analysis, By End User 16.10. South America Brachytherapy Market Forecast, By End User 16.10.1. Hospitals 16.10.2. Specialty Clinics 16.10.3. Others 16.11. South America Brachytherapy Market Value Share Analysis, by Country 16.12. South America Brachytherapy Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Brachytherapy Market Analysis, by Country 16.14. Brazil Brachytherapy Market Forecast, By Technique 16.14.1. High Dose Rate (HDR) Brachytherapy 16.14.2. Low Dose Rate (LDR) Brachytherapy 16.14.3. Pulse Dose Rate (PDR) Brachytherapy 16.14.4. Image Guided Brachytherapy (IGBT) 16.15. Brazil Brachytherapy Market Forecast, By Product 16.15.1. Brachytherapy After Loader 16.15.2. Brachytherapy Applicators 16.15.2.1. Intracavitary Applicators 16.15.2.2. Intraluminal Applicators 16.15.2.3. Interstitial Applicators 16.15.2.4. Intraoperative and Surface Applicators 16.15.3. Brachytherapy Software 16.16. Brazil Brachytherapy Market Forecast, By Application 16.16.1. Prostate Cancer 16.16.2. Breast Cancer 16.16.3. Gynecological Cancer 16.16.4. Cervical Cancer 16.16.5. Skin Cancer 16.16.6. Others (Lung, Head, Neck) 16.17. Brazil Brachytherapy Market Forecast, By End User 16.17.1. Hospitals 16.17.2. Specialty Clinics 16.17.3. Others 16.18. Mexico Brachytherapy Market Forecast, By Technique 16.18.1. High Dose Rate (HDR) Brachytherapy 16.18.2. Low Dose Rate (LDR) Brachytherapy 16.18.3. Pulse Dose Rate (PDR) Brachytherapy 16.18.4. Image Guided Brachytherapy (IGBT) 16.19. Mexico Brachytherapy Market Forecast, By Product 16.19.1. Brachytherapy After Loader 16.19.2. Brachytherapy Applicators 16.19.2.1. Intracavitary Applicators 16.19.2.2. Intraluminal Applicators 16.19.2.3. Interstitial Applicators 16.19.2.4. Intraoperative and Surface Applicators 16.19.3. Brachytherapy Software 16.20. Mexico Brachytherapy Market Forecast, By Application 16.20.1. Prostate Cancer 16.20.2. Breast Cancer 16.20.3. Gynecological Cancer 16.20.4. Cervical Cancer 16.20.5. Skin Cancer 16.20.6. Others (Lung, Head, Neck) 16.21. Mexico Brachytherapy Market Forecast, By End User 16.21.1. Hospitals 16.21.2. Specialty Clinics 16.21.3. Others 16.22. Rest of South America Brachytherapy Market Forecast, By Technique 16.22.1. High Dose Rate (HDR) Brachytherapy 16.22.2. Low Dose Rate (LDR) Brachytherapy 16.22.3. Pulse Dose Rate (PDR) Brachytherapy 16.22.4. Image Guided Brachytherapy (IGBT) 16.23. Rest of South America Brachytherapy Market Forecast, By Product 16.23.1. Brachytherapy After Loader 16.23.2. Brachytherapy Applicators 16.23.2.1. Intracavitary Applicators 16.23.2.2. Intraluminal Applicators 16.23.2.3. Interstitial Applicators 16.23.2.4. Intraoperative and Surface Applicators 16.23.3. Brachytherapy Software 16.24. Rest of South America Brachytherapy Market Forecast, By Application 16.24.1. Prostate Cancer 16.24.2. Breast Cancer 16.24.3. Gynecological Cancer 16.24.4. Cervical Cancer 16.24.5. Skin Cancer 16.24.6. Others (Lung, Head, Neck) 16.25. Rest of South America Brachytherapy Market Forecast, By End User 16.25.1. Hospitals 16.25.2. Specialty Clinics 16.25.3. Others 16.26. South America Brachytherapy Market Attractiveness Analysis 16.26.1. By Technique 16.26.2. By Product 16.26.3. By Application 16.26.4. By End User 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Boston Scientific 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Development Footprint 17.3.2. C4 Imaging 17.3.3. CIVCO Radiotherapy 17.3.4. Concure Oncology’s 17.3.5. Elekta AB 17.3.6. Varian Medical Systems 17.3.7. Theragenics Corporation 17.3.8. iCAD Inc 17.3.9. IsoAid 17.3.10. C. R. Bard, Inc 17.3.11. Sun Nuclear Corporation 17.3.12. Mevion Medical Systems, Inc 17.3.13. IsoRay Medical, Inc 17.3.14. Argon Medical Devices, Inc 17.3.15. Cianna Medical 17.3.16. Eckert & Ziegler 17.3.17. Hitachi, Ltd 17.3.18. Panacea Medical Technologies Pvt. Ltd 17.3.19. Elketa Mexico 18. Primary Key Insights

About This Report

Report ID 66854
Category Electronics
Published Date July 2020
Updated Date
Contact Us